A fatal hypotension by sildenafil in an end-stage renal disease patient with hypertension and abnormal pharmacokinetics of the medicine.
Wada
Yoshihiro
Y
Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Kikuchi
Ken
K
Imamura
Takahisa
T
D000368:Aged; D017809:Fatal Outcome; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D008297:Male; D010879:Piperazines / Q000009:adverse effects* / Q000493:pharmacokinetics; D011687:Purines / Q000009:adverse effects / Q000493:pharmacokinetics; D011744:Pyrimidinones / Q000493:pharmacokinetics; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000009:adverse effects* / Q000493:pharmacokinetics; D014665:Vasodilator Agents / Q000009:adverse effects*
D010879:Piperazines; D011687:Purines; D011744:Pyrimidinones; D013450:Sulfones; C109995:UK 103320; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate